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Abstract
Introduction: Posterior reversible encephalopathy syndrome is a clinical and radiological entity. The most accepted
theory of posterior reversible encephalopathy syndrome is a loss of autoregulation in cerebral blood flow with a
subsequent increase in vascular permeability and leakage of blood plasma and erythrocytes, producing vasogenic
edema. In infection-associated posterior reversible encephalopathy syndrome, a clinical pattern consistent with
systemic inflammatory response syndrome develops. Parainfluenza virus has not been reported in the medical
literature to be associated with posterior reversible encephalopathy syndrome.
Case presentation: We report herein the case of a 54-year-old Caucasian woman with posterior reversible
encephalopathy syndrome associated with parainfluenza virus infection who presented with generalized headache,
blurring of vision, new-onset seizure and flu-like symptoms.
Conclusion: Infection-associated posterior reversible encephalopathy syndrome as well as hypertension-associated
posterior reversible encephalopathy syndrome favor the contribution of endothelial dysfunction to the
pathophysiology of this clinicoradiological syndrome. In view of the reversible nature of this clinical entity, it is
important that all physicians are well aware of posterior reversible encephalopathy syndrome in patients presenting
with headache and seizure activity. A detailed clinical assessment leading to the recognition of precipitant factors
in posterior reversible encephalopathy syndrome is paramount.
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Introduction
Posterior reversible encephalopathy syndrome (PRES) is
a clinical and radiological entity first described by
Hinchey et al. in 1996 [1] and later by Baizabal-Carvallo
et al. [2]. The common clinical features are headache,
seizures, visual changes, altered mental status and focal
neurological signs [3]. In a case series of 13 patients
described by Varaprasad et al.,h e a d a c h ea n ds e i z u r e s
were the most common manifestations [4].
Imaging is essential in the differential diagnosis of
PRES, which includes hypertensive encephalopathy, ure-
mic encephalopathy, lupus cerebritis, meningitis, ence-
phalitis, stroke and cerebral venous thrombosis.
Magnetic resonance imaging (MRI) allows more precise
characterization and recog n i t i o no fP R E St h a nc o m -
puted tomography does [5]. The most common charac-
teristic imaging pattern in PRES seen on MRI is the
presence of edema involving the white matter of the
posterior portions of both cerebral hemispheres. This is
especially true in the parieto-occipital regions, where it
appears in a relatively symmetrical pattern that spares
the calcarine and paramedian parts of the occipital lobes
[6]. However, the brainstem, cerebellum, frontotemporal
cortex and basal ganglia may also be involved. Cortical
involvement was observed in 95.5% of patients in one
case series [2].
In 20% to 30% of patients who develop PRES, blood
pressure is essentially normal at the time of presenta-
tion, a finding that has been reported in many large ser-
ies, including those concerning women with eclampsia,
as well as in patients with cyclosporine toxicity after
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studies and in many isolated case reports [7].
In adult patients, more than 90% have antibodies to
parainfluenza virus. Even in the presence of high levels
of serotype-specific antibodies, primary infection and
reinfection can occur [8]. Parainfluenza virus is asso-
ciated with 1% to 15% of acute respiratory illness in
adults [9].
Case presentation
A 54-year-old Caucasian woman presented to the emer-
gency department (ED) of our institution with uncon-
trolled hypertension and new-onset seizures. Two weeks
prior to this admission the patient’s hypertensive medi-
cation had been switched in a tapered fashion from clo-
nidine to lisinopril because of a reported intolerance in
the form of general malaise, sinus headache and non-
productive cough. Five days before presentation she had
developed generalized headache, blurred vision and nau-
sea, and she decided to visit her closest ED, an outside
facility in Northwestern Massachusetts, which found her
hypertensive with systolic blood pressure of 260 mmHg.
At that time, she was treated with analgesics and par-
enteral antihypertensive medications, which led to par-
tial improvement of her symptoms and subsequent
discharge to her home in rural western Massachusetts.
Twenty-four hours before her hospital admission, she
again visited the ED of the same outside facility com-
plaining of recurrent, severe headaches accompanied by
blurred vision. Her blood pressure recorded at that time
was 260/160 mmHg. She was again treated with intrave-
nous narcotics and antihypertensive’s; however, while
being treated, she developed confusion, and the decision
was made to transfer the patient to our hospital. En
route to our hospital she had an episode of tonic-clonic
seizure activity lasting three to four minutes. In our ED,
she received a dose of 1000 mg intravenous fospheny-
toin once upon arrival and was subsequently intubated
for airway protection because of unresponsiveness. Her
admission blood pressure was 194/115 mmHg, and she
was given two doses of 10 mg of intravenous labetalol.
Her medical history was notable for hypertension, sys-
temic lupus erythematosus (SLE), end-stage renal dis-
ease (ESRD) secondary to lupus nephritis on daily
ambulatory intermittent peritoneal dialysis, with a his-
tory of good dialysis compliance and blood pressure
control. Her most recent peritoneal dialysis treatment
had been the day preceding admission. She had also had
a mechanical aortic valve replacement for a history of
aortic stenosis and underwent chronic anticoagulation
treatment. She was no longer on any immunosuppres-
sive therapy for lupus. She did not use alcohol, tobacco
or recreational drugs. There were no reported sick con-
tacts, recent travel or outdoor exposures.
Her initial laboratory data were relevant for leukocyto-
sis of 16,500 cells/mm
3. No thrombocytopenia or schis-
tocytes were noted on peripheral blood smear. Her liver
panel was normal. Her blood urea nitrogen was 68 mg/
dl with serum creatinine of 5.6 mg/dl. Her baseline
serum creatinine was 5.2 mg/dl. Continuous cycling
peritoneal dialysis was initiated in the Intensive-Care
Unit (ICU). She underwent computed tomography of
the brain, which showed subtle evidence of a possible
acute abnormality in the right occipital lobe in addition
to an unusual pattern of calcifications in the cerebral
hemispheres (Figure 1). The patient underwent lumbar
puncture for cerebrospinal fluid (CSF) analysis, which
showed clear fluid, a white blood cell count of 99 cells/
mm
3, a protein level of 9860 mg/dl and a glucose level
of 53 mg/dl. Her chest X-ray was unremarkable. Empiric
treatment for viral and bacterial meningitis with intrave-
nous acyclovir, vancomycin and ceftriaxone followed.
Her blood and CSF cultures ultimately showed no
growth, and her CSF venereal disease research labora-
tory, herpes simplex and varicella virus polymerase
chain reaction results were negative.
In our ICU, the physical examination revealed an afeb-
rile patient with a blood pressure of 145/92 mmHg
while sedated on propofol and intubated on assist con-
trol ventilation, tidal volume of 550 ml, positive end-
expiratory pressure of 5 cmH2O, oxygen saturation of
100%, fraction of inspired oxygen of 50% and heart rate
Figure 1 Computed tomographic image showing findings in
the brain of a patient with posterior reversible
encephalopathy syndrome. Subtle evidence of a possible acute
abnormality in the right occipital lobe (arrow) in addition to an
unusual pattern of calcification in the cerebral hemispheres.
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fine maculopapular rash not reported on admission. Her
head and neck examination revealed no signs of trauma,
with equal and reactive pupils without subconjunctival
hemorrhage. Her neck was supple without lymphadeno-
pathy. Her neurological examination showed no obvious
posturing or asymmetry; however, she had bilateral
lower-extremity hyperreflexia accompanied by the pre-
sence of a coexistent Babinski sign. Her lungs were clear
to auscultation bilaterally, and her cardiac examination
showed a regular pulse with normal S1 and S2 and an
audible systolic click. No rashes on her palms or soles
were noted. No embolic or immunologic phenomena of
endocarditis were encountered.
On ICU day 2, the patient developed a fever of 102°F,
and a nasopharyngeal direct fluorescent antibody test
was positive for parainfluenza virus, which was con-
firmed by viral cultures for parainfluenza virus type 3.
Lupus activity studies showed normal C3/C4 levels and
elevated complement 50 levels > 60 U/ml. Her anti-
nuclear antibody titer was 1:800 with a homogeneous
nucleolar pattern. Transesophageal echocardiography
showed normal prosthetic valve function and no evi-
dence of vegetations. MRI of the brain without contrast
enhancement was also performed on ICU day two. The
image revealed multifocal T2-weighted hyperintense
lesions present within the parasagittal white matter and
both cerebellar hemispheres (Figure 2).
Discussion
The most accepted theory of PRES is a loss of autoregu-
lation in cerebral blood flow induced by hypertension
with a subsequent increase in vascular permeability and
leakage of blood plasma and erythrocytes, producing
vasogenic edema with petechial hemorrhage [1,2]. A his-
tologic evaluation of PRES is uncommon and is often
obtained late in the course of complex systemic disease.
Activated reactive astrocytes, scattered macrophages and
lymphocytes have often been noted without inflamma-
tion, ischemia or neuronal damage. Three hemispheric
pattern variants may be encountered with similar fre-
quency: holohemispheric, superior frontal sulcal and pri-
mary parietal-occipital [10].
PRES has been less commonly described in the setting
of autoimmune disease, and the distinctive role of SLE
in the pathophysiology of PRES is often clouded by con-
current hypertension and renal disease [11]. To date,
there have been two types of “PRES-SLE” syndromes
described: “hypertensive PRES,” which is reversible with
conventional antihypertensive and anticonvulsive treat-
ments concomitant with inactive SLE, and “immunologi-
cal PRES,” which requires immunosuppressive therapy
and is considered a neurological manifestation of active
SLE [12]. Our patient likely had the former type of
PRES-SLE, given the fact that markers of lupus activity
were normal and her clinical findings were not consis-
tent with cerebral vasculitis or a systemic disease
process.
In infection-associated PRES, a clinical pattern consis-
tent with systemic inflammatory response syndrome
develops with evidence of multiple organ dysfunction
syndrome [10]. A case of an association between influ-
enza A virus and PRES with documentation of cerebral
vasculopathy has been reported [13]. Influenza infection
can precipitate encephalopathy, or encephalitis with the
development of cerebral edema, which might confuse
the initial clinical picture. The case of our patient is
unique in that parainfluenza virus infection has not
been reported in the literature in association with the
development of PRES. Parainfluenza infections are a
common cause of respiratory infection in infants and
children; however, immunocompromised adults can also
be affected [14]. Parainfluenza virus type 3 usually pre-
sents with lower respiratory features (bronchiolitis and
pneumonia), which might have been related to this
patient’s history of flu-like symptoms that triggered the
discontinuation of clonidine, likely representing the
incubation period of the virus, which can extend up to
seven days. No rash has been reported to be associated
with parainfluenza virus [14]. In a study of hematopoie-
tic cell transplant recipients by Peck et al., asympto-
matic parainfluenza virus infection was detected in
17.9% of recipients [15].
Figure 2 M R If i n d i n g si nt h eb r a i no fap a t i e n tw i t hp o s t e r i o r
reversible encephalopathy syndrome. Multifocal, T2-weighted,
hyperintense lesions are present within the parasagittal posterior
parietal lobe, both cerebellar hemispheres, and the occipital lobes
bilaterally (arrows).
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factors, including uncontrolled hypertension, immuno-
suppression due to a history of autoimmune disease and
ESRD, and acute parainfluenza virus infection.
In addition to viral infection and SLE, PRES has also
been associated with high-dose methylprednisolone
therapy, uremic encephalopathy, pheochromocytoma,
Henoch-Schönlein purpura, acute hepatic failure, sickle
cell disease, thrombotic thrombocytopenic purpura,
organ transplantation, HIV infection and gemcitabine
therapy [3,6].
There are no specific guidelines for the management
of hypertension in PRES; however, the general recom-
mendation is to treat all PRES patients presenting with
malignant hypertension with parenteral agents for a goal
reduction in diastolic blood pressure to 100 to 105
mmHg within two to six hours while not exceeding a
decline in mean arterial pressure by more than 25% to
avoid cerebral hypoperfusion and stroke. Those patients
who present with lesser degrees of hypertension should
be managed with smaller incremental changes in blood
pressure decline as per ischemic stroke guidelines [16].
Treatment of PRES generally includes antihypertensive
and/or anticonvulsant therapies and the withdrawal of a
suspected drug if applicable [17]. When seven-day ther-
apy for hypertension and convulsion does not reverse
the manifestation, immunosuppressive treatments are
recommended to reverse PRES [12]. Recurrence of aty-
pical PRES in a hypertensive child with ESRD on perito-
neal dialysis was reported by Girişgen et al.,a n dt h e y
noted infection and sudden increases in blood pressure
as causes for recurrence [18]. In the case series reported
by Varaprasad et al., the duration of hospital stay ranged
from five to 26 days (median of 14 days) and the time to
recovery from PRES was two to 10 days (median of
three and a half days) [4]. Most case reports have
described excellent outcomes; however, one report by
Covarrubias et al. reported mortality of more than 25%
with significant residual neurologic morbidity in survi-
vors as well [19].
Conclusion
Our patient was treated symptomatically, with particular
attention given to aggressive blood pressure control. She
recovered fully with no residual neurological deficit and
with resolution of the generalized body rash, which was
ultimately attributed to an allergic reaction. She was dis-
charged to home nine days after admission to our
institution.
We postulate that our patient experienced an episode
of coexistent hypertensive SLE and infection-associated
PRES precipitated by a combination of uncontrolled
hypertension and parainfluenza virus type 3 infection.
Both associations favor the contribution of endothelial
dysfunction in the pathophysiology of this clinicoradio-
logical syndrome.
In view of the reversible nature of this clinical entity,
it is important that all physicians are well aware of
PRES in patients who present with headache and seizure
activity. A detailed clinical assessment leading to the
recognition of precipitant factors in PRES is paramount,
as early diagnosis and management may have significant
prognostic implications.
Consent
Written informed consent was obtained from the patient
for publication of this manuscript and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Authors’ contributions
OO was a major contributor to analyzing and interpreting the data in this
case, reviewing the literature and writing the manuscript. JH was a major
contributor to the coordination, design and revision of the manuscript
critically for important intellectual content. YO was a major contributor to
reviewing the literature and developing the images. IO was a major
contributor to reviewing the literature. DL was a major contributor to
critically reviewing and revising the manuscript for important intellectual
content. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 21 October 2011 Accepted: 26 March 2012
Published: 26 March 2012
References
1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS,
Lamy C, Mas JL, Caplan LR: Reversible posterior leukoencephalopathy
syndrome. N Engl J Med 1996, 334:494-500.
2. Baizabal-Carvallo JF, Barragán-Campos HM, Padilla-Aranda HJ, Alonso-
Juarez M, Estañol B, Cantú-Brito C, García-Ramos G: Posterior reversible
encephalopathy syndrome as a complication of lupus activity. Clin Neurol
Neurosurg 2009, 111:359-363.
3. Gopalakrishnan CV, Vikas V, Nair S: Posterior reversible encephalopathy
syndrome in a case of postoperative spinal extradural haematoma: case
report and review of literature. Asian Spine J 2011, 5:64-67.
4. Varaprasad IR, Agrawal S, Prabu VN, Rajasekhar L, Kanikannan MA,
Narsimulu G: Posterior reversible encephalopathy syndrome in systemic
lupus erythematosus. J Rheumatol 2011, 38:1607-1611.
5. Staykov D, Schwab S: Posterior reversible encephalopathy syndrome. J
Intensive Care Med 2012, 27:11-24.
6. Marrone LC, Marrone BF, de la Puerta Raya J, Gadonski G, da Costa JC:
Gemcitabine monotherapy associated with posterior reversible
encephalopathy syndrome. Case Rep Oncol 2011, 4:82-87.
7. Bartynski WS: Posterior reversible encephalopathy syndrome, part 2:
controversies surrounding pathophysiology of vasogenic edema. AJNR
Am J Neuroradiol 29:1043-1049.
8. Piedra PA, Englund JA, Glezen WP: Respiratory syncytial virus and
parainfluenza viruses. In Clinical Virology.. 2 edition. Edited by: Richman
DD, Whitley RJ, Hayden FG. Washington, DC: ASM Press; 2002:763-790.
9. Falsey AR, Walsh EE: Viral pneumonia in older adults. Clin Infect Dis 2006,
42:518-524.
10. Bartynski WS: Posterior reversible encephalopathy syndrome part 1:
fundamental imaging and clinical features. AJNR Am J Neuroradiol
29:1036-1042.
11. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA:
Posterior reversible encephalopathy syndrome: associated clinical and
radiologic findings. Mayo Clin Proc 2010, 85:427-432.
Ogunneye et al. Journal of Medical Case Reports 2012, 6:89
http://www.jmedicalcasereports.com/content/6/1/89
Page 4 of 512. Fujieda Y, Kataoka H, Odani T, Otomo K, Kato M, Fukaya S, Oku K, Horita T,
Yasuda S, Atsumi T, Koike T: Clinical features of reversible posterior
leukoencephalopathy syndrome in patients with systemic lupus
erythematosus. Mod Rheumatol 2011, 21:276-281.
13. Bartynski WS, Upadhyaya AR, Boardman JF: Posterior reversible
encephalopathy syndrome and cerebral vasculopathy associated with
influenza A infection: report of a case and review of the literature.
J Comput Assist Tomogr 2009, 33:917-922.
14. Pickering LK, Baker CJ, Kimberlin DW, Long SS: Parainfluenza viral
infections. Red Book: 2009 Report of the Committee on Infectious Diseases. 28
edition. Elk Grove Village, IL: American Academy of Pediatrics; 2009,
485-487.
15. Peck AJ, Englund JA, Kuypers J, Guthrie KA, Corey L, Morrow R,
Hackman RC, Cent A, Boeckh M: Respiratory virus infection among
hematopoietic cell transplant recipients: evidence for asymptomatic
parainfluenza virus. Blood 2007, 110:1681-1688.
16. Vaughan CJ, Delanty N: Hypertensive emergencies. Lancet 2000,
356:411-417.
17. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A,
Tieulié N, Haroche J, Amoura Z, Nieszkowska A, Chastre J, Dormont D,
Piette JC: Posterior reversible encephalopathy syndrome during systemic
lupus erythematosus: four new cases and review of the literature. Lupus
2008, 17:139-147.
18. Girişgen I, Tosun A, Sönmez F, Ozsunar Y: Recurrent and atypical posterior
reversible encephalopathy syndrome in a child with peritoneal dialysis.
Turk J Pediatr 2010, 52:416-419.
19. Covarrubias DJ, Luetmer PH, Campeau NG: Posterior reversible
encephalopathy syndrome: Prognostic utility of quantitative diffusion-
weighted MR images. AJNR Am J Neuroradiol 2002, 23:1038-1048.
doi:10.1186/1752-1947-6-89
Cite this article as: Ogunneye et al.: Parainfluenza virus infection
associated with posterior reversible encephalopathy syndrome: a case
report. Journal of Medical Case Reports 2012 6:89.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ogunneye et al. Journal of Medical Case Reports 2012, 6:89
http://www.jmedicalcasereports.com/content/6/1/89
Page 5 of 5